{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:38:52Z","timestamp":1789227532212,"version":"build-2803163510"},"reference-count":64,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:p>Background: The medium term outcome (over more than one year) of epileptic prodromal AD (epAD) patients treated with antiseizure medications (ASMs) is unknown in terms of seizure response, treatment tolerability, and cognitive and functional progression. Objective: To describe such medium term outcome over a mean of 5.1\u00b12.1 years. Methods: We retrospectively compared 19 epAD patients with 16 non-epileptic prodromal AD (nepAD) patients: 1) at baseline for demographics, medical history, cognitive fluctuations (CFs), psychotropic medications, MMSE scores, visually rated hippocampal atrophy, CSF neurodegenerative biomarkers, and standard EEG recordings; 2) during follow-up (FU) for psychotropic medications, MMSE progression, and conversion to dementia. In the epAD group, we analyzed baseline and FU types of seizures as well as each line of ASM with the corresponding efficacy and tolerability. Results: At baseline, the epAD group had more CFs than the nepAD group (58% versus 20%, p\u200a=\u200a0.03); focal impaired awareness seizures were the most common type (n\u200a=\u200a12, 63.1%), occurring at a monthly to quarterly frequency (89.5%), and were well controlled with monotherapy in 89.5% of cases (including 63.1% seizure-free individuals). During FU, treated epAD patients did not differ significantly from nepAD patients in MMSE progression or in conversion to dementia. Conclusion: Epilepsy is commonly controlled with ASMs over the medium term in epAD patients, with similar functional and cognitive outcomes to nepAD patients. Pathophysiologically, epilepsy is likely to be an ASM-modifiable cognitive aggravating factor at this stage of AD.<\/jats:p>","DOI":"10.3233\/jad-221197","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T06:36:33Z","timestamp":1687588593000},"page":"1057-1074","source":"Crossref","is-referenced-by-count":26,"title":["Epileptic Prodromal Alzheimer\u2019s Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition"],"prefix":"10.1177","volume":"94","author":[{"given":"Geoffroy","family":"Hautecloque-Raysz","sequence":"first","affiliation":[{"name":"Centre M\u00e9moire, de Ressources et de Recherche d\u2019Alsace (Strasbourg-Colmar), Strasbourg, France"},{"name":"Service de Neurologie, Hospices Civils de Colmar, Colmar, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sellal","sequence":"additional","affiliation":[{"name":"Centre M\u00e9moire, de Ressources et de Recherche d\u2019Alsace (Strasbourg-Colmar), Strasbourg, France"},{"name":"Service de Neurologie, Hospices Civils de Colmar, Colmar, France"},{"name":"Unit\u00e9 INSERM U-1118, Facult\u00e9 de M\u00e9decine de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bousiges","sequence":"additional","affiliation":[{"name":"Service de Neurologie, Hospices Civils de Colmar, Colmar, France"},{"name":"University Hospital of Strasbourg, Laboratory of Biochemistry and Molecular Biology, and CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), UMR7364, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Phillipi","sequence":"additional","affiliation":[{"name":"Centre M\u00e9moire, de Ressources et de Recherche d\u2019Alsace (Strasbourg-Colmar), Strasbourg, France"},{"name":"Unit\u00e9 de Neuropsychologie, Service de Neurologie des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"University of Strasbourg and CNRS, ICube laboratory UMR 7357 and FMTS (F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg), team IMIS\/Neurocrypto Strasbourg, Strasbourg, France"},{"name":"Centre de Comp\u00e9tences des d\u00e9mences rares des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[{"name":"Centre M\u00e9moire, de Ressources et de Recherche d\u2019Alsace (Strasbourg-Colmar), Strasbourg, France"},{"name":"Unit\u00e9 de Neuropsychologie, Service de Neurologie des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"University of Strasbourg and CNRS, ICube laboratory UMR 7357 and FMTS (F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg), team IMIS\/Neurocrypto Strasbourg, Strasbourg, France"},{"name":"Centre de Comp\u00e9tences des d\u00e9mences rares des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cretin","sequence":"additional","affiliation":[{"name":"Centre M\u00e9moire, de Ressources et de Recherche d\u2019Alsace (Strasbourg-Colmar), Strasbourg, France"},{"name":"Unit\u00e9 de Neuropsychologie, Service de Neurologie des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"University of Strasbourg and CNRS, ICube laboratory UMR 7357 and FMTS (F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg), team IMIS\/Neurocrypto Strasbourg, Strasbourg, France"},{"name":"Centre de Comp\u00e9tences des d\u00e9mences rares des H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221197_ref1","unstructured":"World Health Organization (2023) Dementia. Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.3233\/JAD-221197_ref2","doi-asserted-by":"crossref","first-page":"afac010","DOI":"10.1093\/ageing\/afac010","article-title":"Bi-directional associations of epilepsy with dementia and Alzheimer\u2019s disease: A systematic review and meta-analysis of longitudinal studies","volume":"51","author":"Dun","year":"2022","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-221197_ref3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-150096","article-title":"Epileptic prodromal Alzheimer\u2019s disease, a retrospective study of 13 new cases: Expanding the spectrum of Alzheimer\u2019s disease to an epileptic variant?","volume":"52","author":"Cretin","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221197_ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: Causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221197_ref5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-221197_ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1528-1167.2010.02909.x","article-title":"A perfect storm: Converging paths of epilepsy and Alzheimer\u2019s dementia intersect in the hippocampal formation","volume":"52","author":"Noebels","year":"2011","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/ADR-200286","article-title":"Temporal lobe epilepsy and Alzheimer\u2019s disease: From preclinical to clinical evidence of a strong association","volume":"5","author":"Tombini","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"key":"10.3233\/JAD-221197_ref8","first-page":"258","article-title":"Effect of seizures on progression of dementia of the Alzheimer type","volume":"6","author":"Volicer","year":"1995","journal-title":"Dementia"},{"key":"10.3233\/JAD-221197_ref9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3389\/fneur.2019.01266","article-title":"A longitudinal study of epileptic seizures in Alzheimer\u2019s disease","volume":"10","author":"Baker","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-221197_ref10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: A randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221197_ref11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221197_ref12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal dementia","volume":"60","author":"Beagle","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221197_ref13","first-page":"CD011922","article-title":"Treatment of epilepsy for people with Alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-221197_ref14","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00415-018-8971-z","article-title":"Cognitive and fatigue side effects of anti-epileptic drugs: An analysis of phase III add-on trials","volume":"265","author":"Sarkis","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JAD-221197_ref15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.3233\/JAD-221197_ref16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2014 beyond controversies, towards aconsensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-221197_ref17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221197_ref18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: A practical clinicaldefinition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by theinternational league against epilepsy: Position paper of the ILAEcommission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizures in patients with Alzheimer\u2019s disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref21","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.3233\/JAD-221197_ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-221197_ref23","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-221197_ref24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002093-200010000-00008","article-title":"Transient epileptic amnesia in dementia: A treatable unrecognized cause of episodic amnestic wandering","volume":"14","author":"Rabinowicz","year":"2000","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-221197_ref25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yebeh.2014.04.014","article-title":"Transient epileptic amnesia mistaken for mild cognitive impairment? A high-density EEG study","volume":"36","author":"Del Felice","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-221197_ref26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.2002.002576","article-title":"Fluctuating cognition in dementia with Lewy bodies and Alzheimer\u2019s disease is qualitatively distinct","volume":"75","author":"Bradshaw","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-221197_ref27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-221197_ref28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition ofdrug resistant epilepsy: Consensus proposal by the ad hoc Task Forceof the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: Diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-221197_ref31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MRsignal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normalaging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am J Roentgenol"},{"key":"10.3233\/JAD-221197_ref32","first-page":"e106","article-title":"Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221197_ref33","doi-asserted-by":"crossref","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","article-title":"Association of epileptiform abnormalities and seizures in Alzheimer disease","volume":"95","author":"Lam","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-221197_ref34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yebeh.2008.08.012","article-title":"Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome","volume":"14","author":"Rao","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-221197_ref35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.seizure.2014.07.008","article-title":"Can the syndrome of transient epileptic amnesia be the first feature of Alzheimer\u2019s disease?","volume":"23","author":"Cretin","year":"2014","journal-title":"Seizure"},{"key":"10.3233\/JAD-221197_ref36","doi-asserted-by":"crossref","first-page":"230.e3","DOI":"10.1016\/j.genhosppsych.2013.10.015","article-title":"Epileptic seizure presenting as dementia with Lewy bodies","volume":"36","author":"Park","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.3233\/JAD-221197_ref37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","article-title":"Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: A long-term EEG study","volume":"132","author":"Horvath","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JAD-221197_ref38","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","article-title":"Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: A prospective observational study","volume":"14","author":"Belcastro","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-221197_ref39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s007020050059","article-title":"Antiglutamatergic therapy in Alzheimer\u2019s disease\u2013effects oflamotrigine","volume":"105","author":"Tekin","year":"1998","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-221197_ref40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2012.11.041","article-title":"Outcome of newly-diagnosed epilepsy in older patients","volume":"27","author":"Besocke","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-221197_ref41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40266-020-00826-2","article-title":"Treatment of seizures in older patients with dementia","volume":"38","author":"Cretin","year":"2021","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-221197_ref42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01444.x","article-title":"Risk of recurrence after a first unprovoked seizure","volume":"49","author":"Berg","year":"2008","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-221197_ref43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-221197_ref44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ene.12336","article-title":"Cerebrospinal fluid biomarkers of \u03b2-amyloid metabolism and neuronal damage in epileptic seizures","volume":"21","author":"Shahim","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-221197_ref45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.3233\/JAD-221197_ref46","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1007\/s00415-019-09400-2","article-title":"In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer\u2019s disease","volume":"266","author":"Terada","year":"2019","journal-title":"J Neurol"},{"key":"10.3233\/JAD-221197_ref47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(94)90017-5","article-title":"Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain","volume":"643","author":"Cruickshank","year":"1994","journal-title":"Brain Res"},{"key":"10.3233\/JAD-221197_ref48","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JAD-221197_ref49","doi-asserted-by":"crossref","first-page":"64745","DOI":"10.18632\/oncotarget.17371","article-title":"Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer\u2019s disease and other tauopathies","volume":"8","author":"Florenzano","year":"2017","journal-title":"Oncotarget"},{"issue":"Pt A","key":"10.3233\/JAD-221197_ref50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yebeh.2019.06.033","article-title":"Increased CSF tau is associated with a higher risk ofseizures in patients with Alzheimer\u2019s disease","volume":"98","author":"T\u00e1buas-Pereira","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-221197_ref51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221197_ref52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jalz.2007.10.018","article-title":"Prognosis of Alzheimer\u2019s disease today: A two-yearprospective study in 686 patients from the REAL-FR Study","volume":"4","author":"Cortes","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221197_ref53","doi-asserted-by":"crossref","first-page":"M49","DOI":"10.1093\/gerona\/50A.1.M49","article-title":"Cognitive decline in Alzheimer\u2019s disease: A longitudinal investigation of risk factors for accelerated decline","volume":"50A","author":"Teri","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-221197_ref54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: A retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221197_ref55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-221197_ref56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1176\/appi.neuropsych.15060143","article-title":"Clinical and neurophysiologic characteristics of unprovoked seizures in patients diagnosed with dementia","volume":"28","author":"Sarkis","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-221197_ref57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000093664","article-title":"Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer\u2019s disease","volume":"22","author":"Lozsadi","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-221197_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","article-title":"Storm before the quiet: Neuronal hyperactivity and A\u03b2 in the presymptomatic stages of Alzheimer\u2019s disease","volume":"36","author":"Stargardt","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221197_ref59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/awz381","article-title":"Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy","volume":"143","author":"Gourmaud","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-221197_ref60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12779\/dnd.2018.17.4.156","article-title":"Association of Alzheimer\u2019s disease with the risk of developing epilepsy: A 10-year nationwide cohort study","volume":"17","author":"Lyou","year":"2019","journal-title":"Dement Neurocogn Disord"},{"key":"10.3233\/JAD-221197_ref61","doi-asserted-by":"crossref","first-page":"e1429","DOI":"10.1212\/WNL.0000000000006319","article-title":"Antiepileptic drug treatment after an unprovoked first seizure: A decision analysis","volume":"91","author":"Bao","year":"2018","journal-title":"Neurology"},{"key":"10.3233\/JAD-221197_ref62","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.seizure.2013.05.020","article-title":"Understanding referral patterns to an epilepsy clinic: Professional perceptions of factors influencing the referral of older adults","volume":"22","author":"Blank","year":"2013","journal-title":"Seizure"},{"key":"10.3233\/JAD-221197_ref63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221197_ref64","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:01Z","timestamp":1777370881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221197"}},"subtitle":[],"editor":[{"given":"Mario","family":"Tombini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":64,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-221197","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}